Join MySLAS Social

About SLAS

Society for Biomolecular Sciences

Society for Biomolecular SciencesThe Society for Biomolecular Sciences was originally founded as the Society for Biomolecular Screening in 1994 to provide a forum for global education and information exchange among professionals in the chemical, pharmaceutical, biotech, and agrochemical industries.

The society was devoted to increasing interdisciplinary education and communication among organic and biochemists, molecular and cellular biologists, microbiologists, pharmacologists, genomics and proteomics specialists, nano- and robotics technicians, toxicologists, and information and data management specialists. SBS also was committed to fostering collaborations among industry, academia and government, and to promoting the highest quality and standards in all areas of drug discovery.

As the field of drug discovery grew, SBS membership kept pace. International in scope, the society’s membership in 2010 included leading innovators, inventors, scientists, researchers, and drug developers from more than 30 countries, 400 companies, and 40 universities.

Every year for 16 years, SBS presented the only non-profit scientific and industry conference on molecular screening, presenting new research and information on the latest breakthroughs in drug discovery, trends, technologies and equipment. SBS conferences were renowned for the quality, credibility, and expertise of their presenters.

More than 1,700 eminent scientists, innovators, and researchers — as well as industry analysts representing a broad range of disciplines and companies from around the world — regularly attended the SBS annual conference and exhibition to learn about the latest trends and basic and applied research that were transforming the way pharmaceuticals were developed.

SBS continued to expand its mission with focused scientific symposia and conferences, in-depth online virtual learning programs, technical committees, special interest groups, a technical standards program, wide-ranging awards program, peer-reviewed journal (Journal of Biomolecular Screening), membership newspaper (SBS News), and an e-newsletter (The Buzz@SBS).

SBS was founded with the generous support of 13 insightful companies from around the world.

  • Amersham International plc (UK)
  • ARRT Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Berlex Biosciences (USA)
  • ComGenex Ltd. (Hungary)
  • FMC Corporation (USA)
  • MDL Information Systems, Inc. (USA)
  • Packard Instrument Company (USA)
  • EG&G Wallac
  • Panlabs Inc. (USA)
  • Pfizer, Inc. (USA)
  • Robocon Labor-und Industrieroboter Ges.m.g.H. (Austria)
  • Zeneca Pharmaceuticals (UK)